Submission systemSubmit
Advanced Search
Volume 2 Issue 4
Oct.  2022
Turn off MathJax
Article Contents
Article Navigation >  Frigid Zone Medicine  > 2022  >  2(4): 251-256
Zhidan Sun, Yan Hou, Zheng Zhang, Benzhi Cai, Jinliang Li. Electrocardiogram abnormalities and higher body mass index as clinically applicable factors for predicting poor outcome in patients with coronavirus disease 2019[J]. Frigid Zone Medicine, 2022, 2(4): 251-256. doi: 10.2478/fzm-2022-0032
Citation: Zhidan Sun, Yan Hou, Zheng Zhang, Benzhi Cai, Jinliang Li. Electrocardiogram abnormalities and higher body mass index as clinically applicable factors for predicting poor outcome in patients with coronavirus disease 2019[J]. Frigid Zone Medicine, 2022, 2(4): 251-256. doi: 10.2478/fzm-2022-0032
shu

Electrocardiogram abnormalities and higher body mass index as clinically applicable factors for predicting poor outcome in patients with coronavirus disease 2019

doi: 10.2478/fzm-2022-0032
  • 1.

    Department of Pharmacy, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China

  • 2.

    Department of Epidemiology and Biostatistics, Public Health School, Harbin Medical University, Harbin 150081, China

  • 3.

    Department of Critical Care Medicine, Harbin Infectious Disease Hospital, Harbin 150030, China

  • 4.

    Department of Cardiology, Harbin Infectious Disease Hospital, Harbin 150030, China

More Information
  • Corresponding author: Benzhi Cai, E-mail: caibenzhi@163.com; Jinliang Li, E-mail: ccworkshop@126.com
  • Received Date: 2021-12-20
  • Accepted Date: 2022-09-02
    • Available Online: 2022-10-30
    Abstract
  •   Background  Patients with coronavirus disease 2019 (COVID-19) have high resource utilization. Identifying the causes of severe COVID-19 is helpful for early intervention to reduce the consumption of medical resources.  Methods  We included 103 patients with COVID-19 in this single-center observational study. To evaluate the incidence, predictors, and effects of COVID-19, we analyzed demographic information, laboratory results, comorbidities, and vital signs as factors for association with severe COVID-19.  Results  The incidence of severe COVID-19 was 16.5% and the percent poor outcome (including mortality, entering in ICU or transferred to a superior hospital) was 6.8%. The majority of severe COVID-19 patients had abnormal electrocardiogram (ECG) (82.35%), hypertension (76.47%) and other cardiac diseases (58.82%). Multivariate logistic regression was used to determine the predictors of severe illness. Abnormal body mass index (BMI) and ECG (P < 0.05) were independent predictors of severe COVID-19. ECG abnormality was associated with increased odds of poor outcome (area under the receiver operating characteristic curves [AUC], 0.793; P = 0.010) and severe COVID-19 (AUC, 0.807; P < 0.0001). Overweight was also associated with increased odds of poor outcome (AUC, 0.728; P = 0.045) and severe illness COVID-19 (AUC, 0.816; P < 0.0001).  Conclusion  Overweight and electrophysiological disorders on admission are important predictors of prognosis of patients with COVID-19.

     

    • FullText(HTML)
  • loading
    • References(23)
  • [1]
    Cui J, Li F, Shi Z L. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol, 2019; 17(3): 181-192. doi: 10.1038/s41579-018-0118-9
    [2]
    World Health Organization. Coronavirus disease (COVID-19) situation reports. 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/. Accessed
    [3]
    Grasselli G, Zangrillo A, Zabella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2. JAMA, 2020; 323(16): 1574-1581. doi: 10.1001/jama.2020.5394
    [4]
    Huang C L, Wang Y M, Li X W, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020; 395(10223): 497-506. doi: 10.1016/S0140-6736(20)30183-5
    [5]
    Rashedi J, Poor B M, Asgharzadeh V, et al. Risk factors for COVID-19. Infez Med, 2020; 28(4): 469-474.
    [6]
    Fresán U, Guevara M, Elía F, et al. Independent role of severe obesity as a risk factor for COVID-19 hospitalization: a Spanish population-based cohort study. Obesity(Silver Spring), 2021; 29(1): 29-37.
    [7]
    Ehmann L, Simon P, Busse D, et al. Risk of target non-attainment in obese compared to non-obese patients in calculated linezolid therapy. Clin Microbiol Infect, 2020; 26(9): 1222-1228. doi: 10.1016/j.cmi.2020.04.009
    [8]
    Zhang J J, Cao Y Y, Tan G, et al. Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients. Allergy, 2021; 76(2): 533-550. doi: 10.1111/all.14496
    [9]
    Gao L, Liang D, Wen X S, et al. Prognostic value of NT-proBNP in patients with severe COVID-19. Respir Res, 2020; 21(1): 83. doi: 10.1186/s12931-020-01352-w
    [10]
    Bompard F, Monnier H, Saab I, et al. Pulmonary embolism in patients with COVID-19 pneumonia. Eur Respir J, 2020; 56(1): 2001365. doi: 10.1183/13993003.01365-2020
    [11]
    Petrakis D, Margină D, Tsarouhas K, et al. Obesity-a risk factor for increased COVID-19 prevalence, severity and lethality. Mol Med Rep, 2020; 22(1): 9-19. doi: 10.3892/mmr.2020.11127
    [12]
    Zhou Y, Chi J, Lv W, et al. Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19). Diabetes Metab Res Rev, 2021; 37(2): e3377.
    [13]
    Wirth R, Becker C, Djukic M, et al. COVID-19 in old age-The geriatric perspective. Z Gerontol Geriatr, 2021; 54(2): 152-160. doi: 10.1007/s00391-021-01864-0
    [14]
    Li X C, Xu S Y, Yu M Q, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol, 2020; 146(1): 110-118. doi: 10.1016/j.jaci.2020.04.006
    [15]
    Gao F, Zheng K I, Wang X B, et al. Obesity is a risk factor for greater COVID-19 severity. Diabetes Care, 2020; 43(7): e72-e74. doi: 10.2337/dc20-0682
    [16]
    Guo T, Fan Y Z, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol, 2020; 5(7): 811-818. doi: 10.1001/jamacardio.2020.1017
    [17]
    Zeng J H, Wu W B, Qu J X, et al. Cardiac manifestations of COVID-19 in Shenzhen, China. Infection, 2020; 48(6): 861-870. doi: 10.1007/s15010-020-01473-w
    [18]
    Chen W L, Kuo C D. Characteristics of heart rate variability can predict impending septic shock in emergency department patients with sepsis. Acad Emerg Med, 2007; 14(5): 392-397. doi: 10.1197/j.aem.2006.12.015
    [19]
    de Castilho F M, Ribeiro A L P, da Silva J L P, et al. Heart rate variability as predictor of mortality in sepsis: A prospective cohort study. PLoS One, 2017; 12(6): e0180060. doi: 10.1371/journal.pone.0180060
    [20]
    Liu Y, Du X, Chen J, et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect, 2020; 81(1): e6-e12. doi: 10.1016/j.jinf.2020.04.002
    [21]
    Pan S W, Shu C C, Feng J Y, et al. Microbiological persistence in patients with mycobacterium avium complex lung disease: the predictors and the impact on radiographic progression. Clin Infect Dis, 2017; 65(6): 927-934. doi: 10.1093/cid/cix479
    [22]
    Günel C, Kırdar S, Ömürlü İ K, et al. Detection of the epstein-barr virus, human bocavirus and novel KI and KU polyomaviruses in adenotonsillar tissues. Int J Pediatr Otorhinolaryngol, 2015; 79(3): 423-427. doi: 10.1016/j.ijporl.2015.01.007
    [23]
    Marbus S D, Schweitzer V A, Groeneveld G H, et al. Incidence and costs of hospitalized adult influenza patients in The Netherlands: a retrospective observational study. Eur J Health Econ, 2020; 21(5): 775-785. doi: 10.1007/s10198-020-01172-1
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)  / Tables(4)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (163) PDF downloads(7) Cited by()
    Proportional views
    Related

    Contact Us

    Editorial Office: Frigid Zone Medicine, Editorial Office of Frigid Zone Medicine, Heilongjiang Health Development Research Center, Zhongshan Road 112, Xiangfang District, Harbin, 150036, China

    Tel: 0451-87253028

    E-mail: editorialoffice@frigidzonemedicine.com

    Supported by: Beijing Renhe Information Technology Co., Ltd.    

    Links

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return